A daptive CD4
ϩ and CD8 ϩ T cell responses to self and nonself Ags can be efficiently controlled by regulatory T cells of the CD4 ϩ CD25 ϩ Foxp3 ϩ (T reg ) 3 subset (1) (2) (3) (4) . Although many characteristics of T reg have been elucidated, the kinetics of regulation and suppressive mechanisms during Ag-presentation in vivo are not fully understood.
In vitro studies on the mechanisms of T reg suppression revealed that interaction of surface receptors such as CTLA-4 or membrane TGF-␤ can directly suppress T eff or delete them (5) . Subsequent induction of IL-10 secreting regulatory T cells from the naive T cell pool by T reg has also been observed (6) . The expansion of CD3/CD28 Ab-primed T eff cells can be inhibited by direct cell contact-dependent interactions of T reg with T eff , clearly indicating direct interaction between T reg on T eff (7) . In addition, suppressive effects of human and murine T reg on DC have been observed in vitro and include the down-regulation of MHC II and costimulatory molecules or inhibition of cytokine production (8 -11) . Whether DC are also targets of T reg suppression in vivo is presently unclear.
As already indicated by the in vitro suppressor assays, it became clear that the preactivation of T reg resulted in a stronger suppressive effect due to their requirement of both TCR activation and CD28 costimulation (12) . Therefore, mature DC were more effective in the activation and homeostatic maintenance of T reg in vivo as compared with immature DC (13) (14) (15) . Adjuvant-mediated immunizations after adoptive transfer of TCR-transgenic T reg demonstrated that their proliferative and suppressive activity occurred delayed as compared with the T eff response but an explanation for this effect was not provided (16) . Others have used preactivated T reg for their adoptive transfer studies to ensure a suppressive effect. Under these conditions the transfer of CD25 ϩ T reg could prevent CD25
Ϫ T eff activation in this model of autoimmune diabetes, whereas simultaneous transfer of preactivated T eff and T eff aborted the suppressive effect (17) . Similarly, TLR-mediated maturation or CD40 ligation of DC released them from the control by T reg (18) . Stable associations between preactivated T eff and preactivated T reg were not observed and also the T eff clustering with DC was abrogated in the presence of activated T reg . However, both T eff and T reg interacted with DC, suggesting that T reg suppression in vivo may require DC (17) . This was further supported by the finding that T reg could inhibit the contacts between Ag-specific T eff and peptide-pulsed DC (19) .
Together, accumulating evidence suggests that T reg can directly regulate immunogenic DC functions and thereby convert them to suboptimal or even tolerogenic DC. How regulation of T cell responses occurs in a more physiological setting, where Ag-specific T reg and T eff are simultaneoulsy present in lymphoid organs together with the presenting DC, has not been investigated. We separated CD25
Ϫ T eff and CD25 ϩ T reg from OVA-specific TCRtransgenic DO11.10 mice, and adoptively transferred them together with OVA-loaded DC after three color fluorescence labeling into syngeneic mice to follow the kinetics of T eff cell priming and T reg suppression in the spleen. We demonstrate in vivo that T reg suppression against the nonself Ag OVA occurs late to allow the T eff cell response to develop but limits the magnitude of T eff expansion. T reg activation by TNF-or LPS-matured DC reversely in the down-regulation of the CD80, CD86, PD-L1, and PD-L2 costimulatory molecules from the DC surface. Such regulated DC are then only suboptimal CD4 ϩ T eff cell stimulators. This indirect mechanism may cooperate with a direct suppressive effect of T reg on T eff. T reg effects on DC could not be observed on fully matured or "CD40-licensed" DC. These data indicate that the balanced outcome of T eff priming and T reg suppression at the simultaneous presence of both T cell types can still act on mature DC but is further controlled by further licensing signals.
Materials and Methods

Mice
Female 6-to 8-wk-old BALB/c mice were obtained from Charles River Laboratories or bred in our own facilities under SPF conditions, like the DO11.10 mice (provided by K. Murphy, Washington University School of Medicine, St. Louis, MO). All animal experiments were performed according the German animal protection law as well as after approval and under control of the local authorities.
Abs and FACS analyses
The directly conjugated mAbs CD4-allophycocyanin, CD11c-allophycocyanin, CD40-PE, CD69-PE, CD70-PE, CD80-PE, CD86-PE, MHC II-PE (M5/114), CD25-PE, and biotinylated PD-L1, PD-L2 detected with streptavidin-PE were obtained from BD Pharmingen. The KJ1-26 mAb specific for the DO11.10 TCR was obtained from Caltag Laboratories/Invitrogen. Cells stained for 30 min in the dark on ice as described (20) . The murine Foxp3-PE staining kit was purchased from eBioscience and stained after fixation and permeabilization of the cells as indicated by the manufacturer. Cells were measured with a FACS Canto II (BD Biosciences) and analyzed with the FCS Express software (De Novo Software).
Generation, Ag loading, and maturation of BM-DC
The method for generating BM-DC with GM-CSF has been described in detail before (20) . In brief, BM cells obtained from hind limbs of mice were seeded at 2 ϫ 10 6 per 100 mm petri dish and fed at days 0, 3, and 6 with fresh medium and GM-CSF from a transfected cell line (21) . DC were used at day 7 or 8 for further treatment. Where indicated, DC were incubated with 10 M OVA peptide 327-339 (Sigma-Genosys) over night at 37°C/CO 2 in the presence of the following maturation stimuli that were used at the concentrations 0.1 g/ml LPS (E. coli 0127:B8; SigmaAldrich), 500 U/ml TNF-␣ (PeproTech) or 0.1 g/ml LPS plus 5 g/ml anti-CD40 (NA/LE; BD Pharmingen).
Cryosections and immunofluorescence
Lymph nodes and spleens were removed and immediately frozen in liquid nitrogen. The organs were embedded in Tissue-Tek O.C.T. Compound (Sakura) and stored at Ϫ80°C. The frozen organs were cut into 10 m slices with a Leica CM3050 S Cryostat (Leica) and stored on glass slides at Ϫ20°C. The frozen sections were thawed and air dried for 10 min. For fixation 4% paraformaldehyde (Merck) was used for 20 min at room temperature. After washing with PBS and incubation with 0.1 M glycin for 15 min the sections were incubated for 15 min with a blocking solution of 2% BSA (PAA) and then embedded in Fluoromount mounting medium (Serva Electrophoresis). The Fluorescence analysis was performed with a Leica DMRD research microscope (Leica) connected with a CCD camera and analyzed with Openlab software (Improvision).
Separation of T cell subsets from DO11.10 mice
The spleens were removed from 6-to 8-wk-old DO11.10 mice and a single cell suspension was prepared by grinding the spleen between the rough ends of two slides. The cells were then filtered through with a 70 m Falcon Cell Strainer (BD Bioscience) and the erythrocytes were lysed with 1.6% ammonium chloride solution at 37°C for 5 min. The splenocytes were then depleted from non-CD4 ϩ T cells using the CD4 negative cell isolation kit (Dynal Biotech). The remaining CD4 ϩ T cells were then further positively enriched by MACS technology (Miltenyi Biotec) with a CD25-PE mAb and anti-PE mAb MACS bead conjugate using a MiniMACS Cell Aeparator. The purities of the separated T cell subsets were throughout Ͼ90%. The T reg that were isolated by CD25PE-conjugated beads, injected, and re-analyzed by FACS had lost their CD25PE fluorescence as indicated by isotype control stainings and thus did not interfere with further PE surface stainings of the T reg (data not shown).
Fluorescence labeling of cells
For CFSE-labeling, the cells were adjusted to 2 ϫ 10 7 cells/ml in PBS. The stock solution of CFSE (CFDA SE, Molecular Probes) was diluted in DMSO and PBS following the manufacturers protocol to a concentration of 5 M and then mixed 1:1 with the cell suspension and incubated at room temperature for 10 min before washing with PBS and injection. For labeling with Cell Tracker Blue (CMAC; Molecular Probes/Invitrogen) or Cell Tracker Orange (CMTMR; Molecular Probes/Invitrogen) the cells were adjusted to a concentration of 1 ϫ 10 7 cells/ml in serum-free HL-1 medium (BioWhittaker). The cells were incubated at 37°C in the dark for 45 min with 20 M CMAC or 10 M CMTMR and then washed. After incubation for another 30 min at 37°C in HL-1 medium the cells were suspended in PBS and injected.
Adoptive transfer experiments
Fluorescence-labeled immature of differentially matured DC (as indicated), T reg or T eff were all injected i.v. at the indicated cell numbers into syngeneic BALB/c mice of the same sex. In the experiments where DC and T cells were injected at the same day, the DC were applied first and the T cells 6 h later if not otherwise stated. Subsequent T cell injections were performed at the indicated time points after the last T cell injection. To analyze T cell responses ex vivo the spleens were removed at the indicated time points after the T cell injections.
Isolation of CFSE-labeled OVA-loaded DC from spleens
The splenic single cell suspensions were prepared as described above. Before erythrocyte lysis the spleens were treated with collagenase III (25 g/ml; Sigma-Aldrich) and DNase I (100 g/ml; Sigma-Aldrich) for 30 min. The cells were then stained with CD11c-allophycocyanin and the PE-conjugated mAbs as indicated.
Results
Adoptively transferred T eff and T reg form clusters with coinjected DC in the spleen
To study the interaction of OVA-peptide-loaded DC with Ag-specific CD4
ϩ T eff cells in the presence or absence of T reg , we generated murine DC from bone marrow (BM) with GM-CSF, matured them with LPS, labeled them with CMAC (blue) and injected them i.v. into BALB/c mice. The isolated responder T eff and T reg cell populations from DO11-10 OVA-specific TCR transgenic mice were fluorescence-labeled with CFSE (green) or CMTMR (red) and T eff or T reg were injected individually or together 6 h later. After another 20 h, both individually injected T eff or T reg clustered around DC in the splenic T cell areas (Fig. 1, A and B) , similarly as it has been described after s.c. injection of DC for the draining lymph nodes (22, 23) . This clustering of both T cell types occurred also after concomitant injection ( Fig. 1C) but not in the lymph nodes due to the lack of DC migration into these organs from the blood compartment, as expected (data not shown). DC injected without OVA do not induce clusters and immature DC were poorly interfering with T eff or T reg in vitro and in vivo (data not shown), consistent with previous reports (13, 14) . This indicates that the clustering of both T eff and T reg subsets with peptideloaded mature DC can occur in the spleen.
Activation and proliferation of DO11.10 T reg are reduced as compared with T eff
For a better understanding of these interactions in the spleen at 26 h, we compared the separated activation of both T cell types by injecting mature OVA-loaded DC together with either CFSE-labeled CD25
Ϫ T eff or CD25 ϩ T reg both isolated from DO11.10 mice. As controls for nonstimulatory conditions also immature OVA-loaded DC were coinjected with the T cells. After 24h the spleen cells were removed and analyzed by FACS. T cell analysis was performed by gating on CD4 ϩ KJ1-26 ϩ cells to detect only clonotypic, OVA-specific cells as only 81% of the CD4 ϩ CD25
Ϫ and 61% of the CD4 ϩ CD25 ϩ starting T cell population were KJ1-26 ϩ (Fig. 1D , left), due to rearrangement of transgenic with endogenous TCR chains (24) . As expected, immature DC did not stimulate both T reg and T eff populations (Fig. 1D, right) , similar to immature or mature DC, which were not loaded with OVA Ag (data not shown). With mature OVA-loaded DC CD69 and CD25 were clearly up-regulated on both types of T cells (for T reg a shift into the CD25 high gate) and more pronounced for the CD25 Ϫ T eff subset ( Fig. 1D, right) . When the spleens were removed 4 days after injection and analyzed by FACS, the proliferation of CD4 ϩ KJ1-26 ϩ CD25 ϩ T reg was lower than of the CD4 ϩ KJ1-26 ϩ CD25 Ϫ T eff but both populations remained in their Foxp3 positive or negative state, respectively (Fig. 1E) . Thus, the T eff and T reg populations, which are specific for a nonself peptide in this setting, differ in their activation and proliferation kinetics.
T reg suppress T eff only after delayed T eff transfer
The observed contacts between T eff and OVA-pulsed DC in the spleen induced T cell priming because we observed CD69 and CD25 up-regulation and proliferation upon transfer of the T eff population in the absence of T reg . How this could be influenced by T reg was investigated by coinjections of both T cell subsets. OVAloaded LPS-matured DC were injected together with T reg followed by simultaneous or subsequent CFSE ϩ T eff injections. After 3 days, spleen cells were analyzed. We did not observe any more than basal T cell proliferation in the absence of OVA Ag-loading of the DC (Fig. 2) . However, after transfer of OVA loaded DC together with T eff vigorous CFSE dilution could be detected, independent of the time point of T eff injection. When T eff cells were coinjected simultaneously with T reg at different ratios, the proliferation of FIGURE 1. Similar DC clustering but slower activation and proliferation rate of T reg in the spleen as compared with T eff . A-C, OVA-loaded and LPS-matured BM-DC (1 ϫ 10 7 , BALB/c) were labeled with CMAC (blue) and coinjected i.v. into syngeneic mice together with 8 ϫ 10 6 isolated and CFSE ϩ DO11.10 CD25 Ϫ T eff (green) alone (A), 2 ϫ 10 6 CD25 ϩ T reg (red) alone (B), or CD25 Ϫ T eff and CD25 ϩ T reg together at a ratio of 5:1 (C) 6 h after the DC. Cyrosections of the spleen and the inguinal LN were prepared 20 h after T cell injection. The data are representative for two independent experiments with similar results. For each analysis 2 ϫ 10 5 events were acquired. D, OVA-loaded immature or LPS-matured DC (2 ϫ 10 6 ) were injected i.v. into BALB/c mice and 6 h later 2 ϫ 10 T eff remained unchanged. Suppression of the T eff population was observed only when the T eff were injected 10 or 24 h after the T reg and the extent of suppression was dependent on the T reg :T eff ratio (Fig. 2) .
T reg control the total spleen cellularity and do not prevent but limit the T eff expansion leading to higher T eff numbers in the memory phase
Because T reg were activated with a delay or at reduced levels and needed prestimulation to suppress T eff cells in this setting, we wondered whether at simultaneous transfer with T eff regulation may occur at later stages of the T eff response. For this, T eff and the OVA-loaded DC populations were simultaneously injected i.v. with or without T reg . The expansion of the T eff was followed by counting the total number of spleen cells and the OVA-specific T eff by staining them with the anti-clonotypic Ab KJ1-26 together with a counterstaining for Foxp3 to exclude OVA-specific T reg from the population of expanding effectors. Within the first 2 days after injection the total spleen cellularity and the numbers of OVAspecific T eff increased at parallel levels, independent of the presence or absence of T reg (Fig. 3) . At day 3, the maximum expansion in spleen size and T eff numberswere detected. Here a marked difference could be observed between spleens and OVA-specific T eff cellularities from mice that were injected or not with T reg , indicating that the T reg contributed first to the limitation of the total spleen cellularity, and second, the CD4 ϩ effector T cell expansion. At days 5 and 8, the spleen cellularities remained high while the number of specific T eff declined as a result of the terminated T cell response in the presence of T reg (Fig. 3) . However, the T eff levels in the absence of T reg did not reach the same low plateau as in their presence. The down-regulation of T eff numbers occurred to the same extent and with the same kinetics with or without T reg , indicating that this contraction phase of the T eff response is controlled by other mechanisms than T reg . Nevertheless, the absence of T reg led to the persistence of high T eff levels during the memory phase, similar to what could be detected at the maximum response in the presence of T reg . Together, T reg with specificity for a nonself Ag as in our model may be activated with a delay to allow a productive T eff response against a pathogen but then interfere to control overshooting and chronic immunity and thereby preventing immunopathology. T reg control the total spleen cellularity and do not prevent the T eff response but control the maximal expansion and the termination phase. OVA-loaded LPS-matured DC (1 ϫ 10 7 ) and 1.6 ϫ 10 7 T eff were injected i.v. into BALB/c mice with or without 4 ϫ 10 6 T reg (ratio 5:1). A, At the indicated days after injection spleens were removed, erythrocytes lysed and the total white spleen cell numbers counted. B, FACS analysis of the spleen cells was performed after staining with CD4, KJ1-26, and Foxp3 mAb. CD4 ϩ KJ1-26 ϩ Foxp3 ϩ T reg were gated of the analysis to follow only the CD4 ϩ KJ1-26 ϩ Foxp3 Ϫ T eff expansion. Absolute T eff numbers were calculated from the total spleen cellularity and the percentage of T eff revealed by FACS analysis. Error bars represent the SDs from the means analyzing individual mice from three independent experiments. For each analysis 2 ϫ 10 5 events were acquired.
T reg suppression is characterized by cluster disruption and reduced individual T eff -DC and T eff -T reg contacts
The data so far indicate that T reg suppressive activity occurs delayed in our experimental setting. However, how T eff and T reg interfere under regulatory and nonregulatory conditions as well as the mechanisms of suppression remain unclear. Therefore, we evaluated the cluster formation but also individual cell-cell contacts between the three adoptively transferred cell populations within the spleen under the simultaneous (nonregulatory) and delayed (regulatory) conditions. OVA-loaded mature DC were fluorescence-labeled in blue and T reg in red before transfer. Simultaneously or 24 h later, green-fluorescent T eff were injected. Spleens were removed 24 h after the T eff injections and cryopreserved before serial sectioning. Then we asked whether or not cell clustering could be observed between the three cell types. In contrast to the nonsuppressive simultaneous injections, the cluster formation was completely inhibited under the delayed condition where also T eff suppression was observed and only individual contacts remained (Fig. 4A ). These findings from splenic interactions here are in agreement with other findings derived from DC-T cluster analysis within the lymph node (19) . Further assessment of the individual contacts between the three adoptively transferred populations to each other revealed that the frequency of T reg -DC contacts remained stable under both suppressive (24 h delayed) and nonsuppressive (simultaneous) conditions. However, under suppressive conditions, a reduced frequency of contacts was observed between T eff -DC as well as T reg -T eff (Fig.  4B) , correlating with the cluster disruption (Fig. 4A ). Similar observations have been made in other systems and it had been discussed there whether this may indicate that in vivo the T eff suppression can be mediated also indirectly by T reg activity on the Ag-presenting DC (17) .
T reg induce down-regulation of selected costimulatory molecules on DC
Next, we wanted to elucidate whether mature DC can be influenced by T reg in vivo. DC treated with TNF, LPS, or LPS plus anti-CD40 were analyzed by FACS for surface expression of MHC II, CD80, CD86, PD-L1, and PD-L2 before i.v. injection to analyze their maturation state. These data confirmed their mature surface phenotype as compared with untreated DC (Fig.  5) . Then T eff alone or T reg plus T eff were coinjected according the simultaneous and the 24-h delayed conditions. After another 48 h, in vivo the CFSE ϩ OVA-loaded DC within the spleen were analyzed by FACS for expression of CD11c and a panel of costimulatory molecules. DC injected with T eff only or with simultaneous T reg and T eff transfer maintained their mature phenotype and expressed high levels of MHC II, CD80, CD86, CD40, PD-L1, and PD-L2 as well as moderate levels of ICOS-L and CD70 (Fig. 5 and data not shown) . The latter two markers are absent on immature DC (data not shown). When the regulatory conditions of T eff injection (24 h delayed) were analyzed, a marked down-regulation could be observed for CD80, CD86, T reg derived from DO11.10 mice were injected i.v. into the same recipients. CFSE ϩ T eff (8 ϫ 10 6 ) were injected either simultaneously or with a 24 h delay at a ratio of 5:1 (T eff :T regs ). A, Cryosections were prepared 24 h after the T eff injections to detect cell contacts and clustering by microscopical analysis. B, T eff -DC, T eff -T reg , and T reg -DC contacts were analyzed and quantified. Data shown are from at least two independent experiments where for each of it Ͼ20 cryosections that were analyzed by counting Ͼ3000 cell-cell contacts. Values of p were calculated by unpaired Student's t test ‫,ء(‬ p Ͻ 0.05; ‫,ءء‬ p Ͻ 0.01). PD-L1, and PD-L2 on DC that were matured with TNF or LPS ( Fig. 6 and data not shown). No changes could be observed for the expression of ICOS-L, CD70, CD40, and MHC II (data not shown). Interestingly, DC that had been matured with LPS plus anti-CD40 also did not show a modulation of any surface marker analyzed (Fig. 6B ). The effect of T reg was also not correlated with increased cell death of DC because Annexin V or 7-AAD stainings of the DC after ex vivo isolation remained negative (data not shown). Thus, T reg activity in vivo, which leads to a block of T eff proliferation, may be mediated by the down-regulation of specific costimulatoy molecules from the DC surface, which in turn indirectly controls the T eff expansion.
Licensing of DC through CD40 aborts the suppressive activity of T reg
DC maturation can be performed with various classes of stimuli resulting in different qualities or maturation stages. DC licensing has been described to further enhance DC maturation, e.g., by LPS, to further improve their functional capacities, which are especially required for the priming of CD8 ϩ T cells (25, 26) . To investigate FIGURE 6. T reg downmodulate selected markers from the surface of TNF-and LPS-matured DC but not after LPS/CD40 maturation. A, CFSE ϩ OVA-loaded mature DC (1 ϫ 10 7 ) and 2 ϫ 10 6 DO11.10 derived T reg were injected i.v. into BALB/c mice. DO11.10 T eff (8 ϫ 10 6 ) were injected simultaneously or with a 24 h delay (ratio 5:1, T eff :T reg ). As a control, DC and T eff were also injected without T reg . Spleens were removed and analyzed 48h after injection of the DC. B, The data are representative for three independent experiments with similar results. Statistical evaluations were calculated by unpaired Student's t test ‫,ء(‬ p Ͻ 0.05). For each analysis 2 ϫ 10 5 events were acquired. whether CD40 licensing could play a role on whether T reg suppression of DC may occur or not, DC were matured with the combination of LPS and CD40 mAb and tested in the same setting as for TNF-or LPS-matured DC. The data indicate that the addition of the CD40 stimulus on LPS-matured DC abrogates the downregulation of surface markers by T reg (Fig. 6 ). This indicates that another quality of DC licensing or conditioning through CD40 may include the unresponsiveness to suppressive effects by T reg which then allows unimpaired T cell priming.
To test whether the inhibited down-regulation of the costimulatory molecules from the DC surface by LPS/CD40 treatment would also functionally abort the suppressive capacity of T reg on T eff proliferation, we directly compared OVA loaded DC matured with TNF, LPS, or LPS/CD40 under the 24-h delayed conditions in vivo. Although T eff proliferation was clearly suppressed when TNF or LPS mature DC were injected, the CFSE dilution was only marginally affected after injection of LPS/CD40 matured DC (Fig.  7) . This indicates that T reg suppression of T eff proliferation in vivo is to a large extent mediated through DC and only a partial suppressive effect results from direct influence of T reg on T eff .
Discussion
Currently it is still under debate how regulation may occur in vivo, directly on T eff and/or through DC? In vitro data clearly indicate that T reg suppression can act directly on T eff (7, 27) . Others (8, 10, 11, 28 -30) reported inhibitory effects by T reg on murine and human DC in vitro but such a phenomenon has not been demonstrated in vivo so far. In addition, all of these reports used immature DC which were incubated with various maturation stimuli in the presence or absence of T reg , meaning that the T reg in these settings only prevented DC maturation.
In this study, we used an adoptive transfer system that allowed us to follow the effects of T reg on the T eff priming kinetics induced by mature DC in the spleen. The i.v. route of DC application excludes the secondary modification of the DC in vivo, whereas s.c. injected mature DC can be further influenced in their maturation state and induce bystander effects on endogenous DC after homing to the lymph node (31) . Furthermore, the spleen does not require specific homing receptors for different stages of T eff such as central verus effector memory T cells. Therefore altered homing patterns of activated T eff subsets into the spleen in the presence or absence of T reg can be excluded as a mechanism to explain the lower numbers of T eff . Thus, the i.v. injection route and analysis of the spleen combines several advantages over previous approaches to follow the interaction of differentially matured DC with both CD4 ϩ T cell types (T eff and T reg ), undisturbed from secondary effects.
Our data reveal that T reg can act on TNF-and LPS-matured DC to induce the selective down-regulation of CD80/CD86 and PD-L1/PD-L2, but not MHC II, ICOS-L, CD40, and CD70, from the DC surface. This could point to a specific importance of these molecules not at preventing the T eff response but being decisive during later phases to limit the T eff expansion. Two ligands of the costimulatory molecule pairs on the T cell surface, CTLA-4 and PD-1, respectively, are well accepted to deliver negative signals into T eff and can work in an additive manner (32) . Although CTLA-4 is expressed abundantly on resting T reg (7) , PD-1 is located only intracellularly and up-regulated on activated T reg (33) . Functionally, conflicting results exist for CTLA-4, as the effects mediated by T reg on human DC costimulatory molecule expression have been described as being both CTLA-4-dependent (28) and -independent (29) . A functional role of PD-1 on T reg is not known yet.
Our data also show that the modulatory effect of T reg is not functional after a combined LPS ϩ CD40 maturation, further extending our findings that the quality of DC maturation heavily influences T cell activation and differentiation (34) . Endogenous inflammatory signals such as TNF, TLR ligands such as LPS, or CD40 ligation can result in DC maturation although the stage or quality of maturation are substantially different especially with respect to their cytokine production (35, 36) . Although TNF-matured DC are rather semimature as they do not secrete cytokines and can even act tolerogenic in certain models, LPS will lead to full maturation including IL-12 production and Th type-1 priming (37). Signals through CD40 can also mature DC (38) leading to a socalled "conditioned" or "licensed" state that reflects a superior stimulation as achieved with TLR activation alone because only then it enables an effective priming and cross-priming of CD8 ϩ T cells in vivo (25, 26, 39) . The CD40L (CD154) is expressed on T reg (see below), activated platelets (40) and on CD4
ϩ Th cells (41), The latter two could both serve as a licensing signal for DC. However, CD154 expressed on activated T cells may be encountered by the DC only at later time points after T cell activation in the lymph nodes, whereas CD154 on activated platelets may engage CD40 on DC already at the infection site simultaneously with a microbial TLR ligand. Although CD40 mediated maturation of DC is well established, evidences from our own work (37, 42) and in vivo experiments by others (43) suggest that CD40 Abs alone are insufficient for DC maturation and only the combination with a microbial stimulus such as through TLRs may be sufficient to reach the fully mature or licensed state. This is also supported by our data shown here. However, from the published data it is not entirely clear what renders the licensed state superior to a stage where DC have been matured through a TLR or CD40 alone. Although CD40 signals can enhance TLR-induced IL-12 production by DC, this quantitative effect may be insufficient to explain the qualitative effect on the priming of CD8 ϩ T cells. Recently, it has been shown (10) that CD40 licensing also relieves human DC from T reg activity in vitro in a preventive setting. We can extend on this by showing CD40 licensing also in vivo. Others have reported that in vitro immature murine BM-DC and splenic DC were prevented from up-regulation of costimulatory molecules but when the DC were matured with LPS before adding the T reg , there was no effect on the expression level of DC surface markers (18) . In contrast, we still observe modulatory effects on mature DC after stimulation with TNF or LPS in vivo. These conflicting results may indicate that the in vivo requirements for regulation may be different from in vitro cultures. The reasons for this remain to be investigated.
It is of note that CD154 (CD40L) is also expressed at constitutively low levels by T reg , up-regulated after activation and required for their functionality (44, 45) . In light of this our results may indicate that there are either quantitative differences in CD40L expression between T reg and activated platelets or an early CD40 signal through platelets may desensitize DC for further CD40 signaling by T reg in the lymph node or the signals received by the DC are qualitatively different. The latter possibility could be due to the differential expression of the five splice variants for CD40 existing on immature or mature DC (46) . In this scenario, the CD40 isoforms triggered on immature DC contacting platelets at the site of microbial encounter would be different from the ones triggered by DC, which had matured and migrated into the T cell areas of the lymph node. In fact, three isoforms on mature DC have been shown to rather disable maturation signaling and thereby impair their IL-12 production (46) .
Our kinetic analysis revealed that the total splenic cellularity as well as the number of OVA-specific T eff is reduced only at later stages of the T cell response but not in the initial T cell expansion phase. Our data are similar to analyses of T eff cell expansion controlled by T reg in the draining lymph nodes after immunization with Freund's adjuvant (16) or results about the role of IL-2 as a major mediator to allow T eff expansion before T reg activation and thereby controlling the T eff response (47) . As both systems used nonself Ags in their stimulation of T cells, this may indicate that in such settings the induction of immunity will be mediated by slower activation of nonself specific T reg to allow pathogen defense by T eff . At the maximum of the response T reg may contribute to limit T eff expansion to avoid immunopathology. However, in the termination phase of the T eff response, T eff contraction occurs with a similar kinetics and quantity in the presence or absence of T reg . When the T reg -dependent limitation is lacking and the subsequent T reg -independent contraction has occured, during the following memory phase the cellularity of T eff remains at high levels, similar as they appear at the maximum response in the presence of T reg . The persistence of high T eff numbers can obviously not be further down-regulated by the T reg , probably due to the lack of Ag and thereby T reg activation at this time point.
A possible mechanism for the reduced contacts between T eff -DC and T eff -T reg we observed in the experiments under delayed conditions may also depend on simple competition for the access of the delayed injected T eff to the respective cells. Also the ratio of T eff :T reg , that had been chosen 5:1 in most of our settings, certainly can influence the extent of competition and thus regulation. However, we found many small clusters and two cell interactions in the sections, which would argue against competition. Also others (23) have excluded competition as a mechanism for reduced T cell to DC contacts within murine lymph nodes. Furthermore, it remains to be analyzed whether T cell specificities other than for OVA, due to differential selection of T reg and T eff in the thymus, could influence the kinetics of T reg activity on different types of T eff that may express low vs high affinity TCRs for the same peptide but also in a bystander fashion.
Recently, it has been shown (19) that T reg form stable contacts with DC in vivo, which we also found in our study and this may indicate effects of T reg on DC in vivo. This was then shown in a system where T reg -DC contacts led to a complete loss of significant interactions between T eff with DC, indicating that such direct regulation of T eff may be less important in vivo (17) . In contrast, we still found substantial individual interactions between these two cell types at a level of ϳ50% compared with what we observed in the absence of regulation. This may indicate that in our system T reg may act though both pathways, directly on T eff as well as directly on DC. The latter mechanism may then indirectly result in an impaired T eff activation by the DC and together with the direct suppression by T reg resulting in a potentiated regulatory effect.
In conclusion, our data contribute to the questions why and how T reg can act on mature DC in vivo, but also how DC can evade this T reg control through CD40 licensing. Both phenomena may combine with other mechanisms that control desired immunity against pathogen vs an exacerbated immunopathological reponse.
